Atorvastatin
RANBAXY LAUNCHES ATORVASTATIN IN DENMARK
Published in Lab Business Week, March 11th, 2007
Commenting on the momentous occasion, Malvinder Mohan Singh, CEO & Managing Director, Ranbaxy, said, "The introduction of Atorvastatin in Denmark is a significant milestone in Ranbaxy's Atorvastatin strategy and heralds the beginning of the Company's determined efforts to bring affordable Atorvastatin to patients in Europe and other parts of the world." He further added, "Generic Atorvastatin will bring significant and immediate cost benefits to the Danish healthcare system."
The Company will continue to actively pursue all options in the EU and other markets...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-03-11)
More Articles from Lab Business Week
- Anemia
Reports from The Jackson Laboratory add new data to research in anemia - Bio-Rad Laboratories
BIO-RAD ANNOUNCES THE APPOINTMENT OF NEW BOARD MEMBER - Bioscience
Shedding New Light on Proteorhodopsin - Cancer
Cold Spring Harbor Laboratory Scientists Discover New Gene that Prevents Multiple Types of Cancer - Cancer Vaccines
Carrington Subsidiary DelSite Signs Technology License Agreement With ElSohly Laboratories - Carrington Laboratories, Inc.
Carrington and Racing Legend Johnny Rutherford Sign Endorsement and Personal Services Agreement - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
